Prevention
The Gates Foundation New Anti-HIV Drug Device is Revolutionary

The device is placed under the skin and will release anti-HIV drugs in the body over the course of a single year.
January 03 2017 5:00 AM EST
May 26 2023 1:58 PM EST
By continuing to use our site, you agree to our Private Policy and Terms of Use.
The device is placed under the skin and will release anti-HIV drugs in the body over the course of a single year.
The Bill & Melinda Gates Foundation has teamed up with Intarcia Therapeutics to invest upwards of $140 million with the intent of developing the first once or twice-yearly anti-HIV prophylactic to help prevent the spread of HIV in Sub-Saharan Africa and other countries.
The announcement came on the heels of Intarcia securing $220 million in the second close of the Series EE Equity Financing. A third and final close is planed in the first quarter of 2017.
The initiative is a Medici Drug Delivery System that delivers matchstick-sized devices to be implanted under the skin and release medication continuously. Once placed, water from the extracellular fluid enters the pump device at one end that expands to drive a piston at a controlled rate. This allows the drug within the pump to be released in a steady, consistent fashion at the other end of the device, states the press release. Each design will hold an appropriate volume of drug to treat a person for a whole year.
Researchers are also seeking approval for a device that will do the same thing for people living with diabetes.
“There’s a vital need for an HIV/AIDS intervention that allows those at risk to incorporate prevention more easily into their daily lives,” Sue Desmond-Hellmann, CEO of the Bill & Melinda Gates Foundation, said in a statement. “We feel optimistic about our partnership with Intarcia and the prospect of an implantable prophylactic device that could make a world of difference for people most in need,”
According to Bloomberg, the Gates Foundation is providing $50 million upfront, and will possibly give $90 million more in grants depending on how the program goes.
Be sure to follow
Plus on your favorite social platforms!
Facebook
Instagram
Twitter
Want more news, top stories, and videos? Check out the all NEW Advocate Channel!
Your 24/7 streaming source for equality news and lifestyle trends.
Click this link right now: https://advocatechannel.com